InvestorsHub Logo
Followers 5
Posts 1109
Boards Moderated 0
Alias Born 05/02/2014

Re: Slick Mic post# 10386

Tuesday, 07/15/2014 8:45:09 PM

Tuesday, July 15, 2014 8:45:09 PM

Post# of 140474
Titan will have to have more than one "surgical application" in its pipeline if it is going to take off after any approval. That's all I'm saying. Those "in the pipeline" applications will need to be common knowledge in the robotic surgery investment and medical sphere to maintain any momentum.
It is very, very, very hard to launch and sustain a product like this; high risk, high cost, unproven metrics, additional surgical training, duplication with existing methods, etc., etc.. daVinci was in many ways lucky, but had no competition. Titan has entrenched competition; it's called da Vinci. And ISRG has the resources to change the playing field any way they want to, even pricing. People will not flock to SPORT, FOR ONE PROCEDURE.
Titan needs to be developing, at least in theory, where it will evolve even as it launches. Doing the detail work in secret is fine, but the medical amd investment sphere need to have something to pin a future use(s) onto.
I've seen and been involved with potential medical products developed by the finest doctors, medical centers, tech transfer departments, and universities - only to flounder because the market had no friggin' idea what they would be good for.
Just a warning: Titan needs to promote its purpose, or just wind up as a takeover technology. Fine by me if the price is good.